Researchers are reporting some progress in their search for drugs that tamp down the overwhelming immune reaction that can kill a patient with COVID-19.
Copyright 2021 NPR
Drugs Targeting Immune Response To COVID-19 Show Promise
Corrected: April 6, 2021 at 10:00 PM MDT
An earlier version of this story incorrectly said aviptadil is a monoclonal antibody. In fact, it is a synthetic peptide.
